Share on StockTwits

Neuralstem (NYSE:CUR) Insider Karl Johe sold 6,000 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $4.09, for a total transaction of $24,540.00. Following the completion of the transaction, the insider now directly owns 495,747 shares in the company, valued at approximately $2,027,605. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.

Neuralstem (NYSE:CUR) traded down 3.23% on Wednesday, hitting $3.90. The stock had a trading volume of 648,826 shares. Neuralstem has a one year low of $1.58 and a one year high of $4.81. The stock has a 50-day moving average of $3.37 and a 200-day moving average of $3.77. The company’s market cap is $338.7 million.

Neuralstem (NYSE:CUR) last released its earnings data on Friday, August 8th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.03. Analysts expect that Neuralstem will post $-0.22 EPS for the current fiscal year.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Receive News & Ratings for Neuralstem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.